Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity.

MLA

Sammaraiee, Y., et al. “Evaluation of the Impact of Intrathecal Baclofen on the Walking Ability of People with Multiple Sclerosis Related Spasticity.” Multiple Sclerosis and Related Disorders, vol. 46, Nov. 2020, p. 102503. EBSCOhost, https://doi.org/10.1016/j.msard.2020.102503.

APA

Sammaraiee, Y., Stevenson, V. L., Keenan, E., Buchanan, K., Lee, H., Padilla, H., & Farrell, R. A. (2020). Evaluation of the impact of intrathecal baclofen on the walking ability of people with Multiple Sclerosis related spasticity. Multiple Sclerosis and Related Disorders, 46, 102503. https://doi.org/10.1016/j.msard.2020.102503

Chicago

Sammaraiee, Y, V L Stevenson, E Keenan, K Buchanan, H Lee, H Padilla, and R A Farrell. 2020. “Evaluation of the Impact of Intrathecal Baclofen on the Walking Ability of People with Multiple Sclerosis Related Spasticity.” Multiple Sclerosis and Related Disorders 46 (November): 102503. doi:10.1016/j.msard.2020.102503.